vivanta industries has executed business collaboration agreements with Qness Pharmaceuticals to strengthen its operations in the pharmaceutical sector. The agreements, signed on June 12, 2026, focus on the manufacture, procurement, supply, branding, marketing, and distribution of pharmaceutical and allied products within the domestic market. This strategic move aims to expand the company's product portfolio and enhance its market reach through contract manufacturing and supply arrangements.

The collaboration does not involve any joint venture, equity participation, or share exchange. No upfront consideration has been paid or received as part of the arrangement. Instead, commercial considerations will be determined based on individual purchase orders and mutually agreed commercial terms from time to time. The agreements provide a framework for operations while ensuring that ownership of intellectual property remains with the respective owner.

Qness Pharmaceuticals is a proprietorship concern engaged in the business of pharmaceutical products. The counterparty is not a related party of Vivanta Industries Limited. The Promoters, Promoter Group, and Group Companies of Vivanta Industries Limited have no interest in the said arrangements, and all transactions are proposed to be undertaken on an arm's length basis.

The agreements do not result in any transfer of management or control of Vivanta Industries Limited. Product-wise pricing and operational terms shall be governed through mutually agreed purchase orders. The company expects these arrangements to create opportunities for business growth by leveraging contract manufacturing capabilities.

In the event that the arrangements are terminated or called off for any reason, Vivanta Industries Limited will make appropriate disclosures to the Stock Exchange along with the reasons thereof. This will be done in accordance with the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Details of the Agreement

Vivanta Industries Limited returned to profitability in the financial year ended March 31, 2026, reporting a consolidated net profit of ₹60.02 lakh compared to a net loss of ₹132.22 lakh in the previous year. This recovery was primarily led by a substantial increase in revenue from operations, which surged to ₹25008.61 lakh from ₹10980.34 lakh in FY25. The company’s standalone financial results also reflected a positive shift, recording a net profit of ₹41.48 lakh for the year against a loss of ₹119.57 lakh in the preceding year.

Financial Performance

The audited financial results for the quarter and year ended March 31, 2026, were approved by the Board of Directors on May 28, 2026. On a consolidated basis, total income for FY26 stood at ₹25333.54 lakh, a significant rise from ₹11037.92 lakh in the previous year. For the quarter ended March 31, 2026, the company reported a consolidated net loss of ₹80.37 lakh, while revenue from operations for the quarter was ₹3824.85 lakh.

On a standalone basis, the company recorded a total income of ₹4674.32 lakh for FY26, up from ₹2336.09 lakh in the previous year. The standalone net profit for the year was ₹41.48 lakh. The statutory auditors, GMCA & Co., carried out the audit under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and confirmed the results provide a true and fair view.

Strategic Expansion and Governance

The Board approved the adoption of a new line of business in the Electric Vehicle (EV) Charging Infrastructure and allied energy solutions sector. The company stated this diversification aligns with its long-term strategy to explore environmentally sustainable and high-growth business opportunities driven by government initiatives and increasing EV adoption. The investment will be made in a phased manner based on business requirements and feasibility assessments.

In governance matters, the Board appointed M/s. Dharti Shah & Co., Chartered Accountants, as the Internal Auditor for the financial year 2026-2027. Additionally, CS Devang Shah was appointed as the Nodal Officer for the Investor Education and Protection Fund Authority (IEPFA) to coordinate and file necessary forms. The Board also approved the issue of duplicate share certificates to shareholders who reported loss of original certificates.